Clover Health Investments, Corp. (CLOV) stock
CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
$4.73−0.22 (-4.44%)
Close on Nov 17, 2026Market cap $2.51BP/E –Yield –
Clover Health Investments free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Clover Health Investments's free cash flow for the twelve months ending Jun 30, 2026 was $74.21M. For fiscal 2025 it was -$68.98M, down 307.2% from the year before. The highest annual figure on record is $33.29M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$68.98M | -307.2% |
| FY2024 | Dec 31, 2024 | $33.29M | – |
| FY2023 | Dec 31, 2023 | -$145.25M | – |
| FY2022 | Dec 31, 2022 | -$208.39M | – |
| FY2021 | Dec 31, 2021 | -$283.05M | – |
| FY2020 | Dec 31, 2020 | -$119.19M | – |
| FY2019 | Dec 31, 2019 | -$159.90M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $24.51M | +406.4% |
| Q1 FY2026 | Mar 31, 2026 | $107.04M | – |
| Q4 FY2025 | Dec 31, 2025 | -$68.75M | – |
| Q3 FY2025 | Sep 30, 2025 | $11.41M | -77.0% |
| Q2 FY2025 | Jun 30, 2025 | $4.84M | -89.1% |
| Q1 FY2025 | Mar 31, 2025 | -$16.48M | -164.6% |
| Q4 FY2024 | Dec 31, 2024 | -$86.15M | – |
| Q3 FY2024 | Sep 30, 2024 | $49.59M | – |
| Q2 FY2024 | Jun 30, 2024 | $44.36M | -16.0% |
| Q1 FY2024 | Mar 31, 2024 | $25.49M | -67.6% |
| Q4 FY2023 | Dec 31, 2023 | -$257.82M | – |
| Q3 FY2023 | Sep 30, 2023 | -$19.02M | -118.8% |
| Q2 FY2023 | Jun 30, 2023 | $52.82M | – |
| Q1 FY2023 | Mar 31, 2023 | $78.78M | – |
| Q4 FY2022 | Dec 31, 2022 | -$213.25M | – |
| Q3 FY2022 | Sep 30, 2022 | $101.40M | – |
| Q2 FY2022 | Jun 30, 2022 | -$39.34M | – |
| Q1 FY2022 | Mar 31, 2022 | -$57.20M | – |
| Q4 FY2021 | Dec 31, 2021 | -$80.41M | – |
| Q3 FY2021 | Sep 30, 2021 | -$45.32M | – |
| Q2 FY2021 | Jun 30, 2021 | -$64.35M | -594.6% |
| Q1 FY2021 | Mar 31, 2021 | -$92.97M | – |
| Q4 FY2020 | Dec 31, 2020 | -$59.97M | – |
| Q3 FY2020 | Sep 30, 2020 | -$34.82M | – |
| Q2 FY2020 | Jun 30, 2020 | $13.01M | – |
| Q1 FY2020 | Mar 31, 2020 | -$37.42M | – |
See a number that looks wrong?